UPA - UPRET 60mg (Retatrutide) | Self-Mix Vial
UPRET 60mg
Retatrutide
1 x 60mg Multi-Dose Vial
1 x 2ml Bacteriostatic Water Ampoule
UPRET 60mg Retatrutide | Self-Mix Vial
UPA UPRET 60mg is a self-mix vial labelled as containing 60mg of retatrutide. Retatrutide is an investigational triple hormone receptor agonist that activates GIP, GLP-1 and glucagon receptors involved in appetite, glucose regulation and energy metabolism.
What UPRET 60mg Is Used For
Retatrutide is currently being researched for:
Supporting significant body-weight reduction
Helping to reduce appetite and food intake
Supporting blood-glucose control
Improving certain metabolic health markers
Supporting the management of obesity and related metabolic conditions
Phase 3 trials have reported substantial weight reduction, but retatrutide remains investigational and is not yet an approved medicine.
How UPRET 60mg Works
Retatrutide simultaneously activates three metabolic hormone receptors:
GLP-1 receptors – involved in appetite, satiety and glucose regulation
GIP receptors – involved in insulin response and metabolic regulation
Glucagon receptors – involved in energy metabolism and expenditure
This triple-receptor activity distinguishes retatrutide from single- and dual-receptor incretin therapies.
How to Use UPRET 60mg
As a self-mix vial, the product requires appropriate reconstitution before administration.
Retatrutide remains investigational, so there is currently no regulator-approved dosing schedule for commercially sold retatrutide products.
Administration Route: In clinical trials, retatrutide is administered by subcutaneous injection once weekly.
Dosage Information
Total labelled content per vial: 60mg Retatrutide
Clinical trials have evaluated several doses using gradual dose escalation. Because retatrutide remains investigational, dosing should not be assumed from non-approved product instructions and should be discussed with a qualified healthcare professional.
Possible Side Effects
Clinical studies have most commonly reported gastrointestinal side effects, particularly during dose escalation.
Common
Nausea
Diarrhoea
Vomiting
Constipation
Decreased appetite
Comments (0)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent